FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024868083> ?p ?o ?g. }

• W2024868083 endingPage "1081" @default.
• W2024868083 startingPage "1073" @default.
• W2024868083 abstract "In Brief Purpose: To evaluate visual axis opacification after AcrySof® intraocular lens (IOL) (Alcon) implantation in pediatric eyes. Setting: Iladevi Cataract and IOL Research Centre, Ahmedabad, India. Methods: This prospective study evaluated 103 consecutive eyes of 72 children with congenital cataract. Two groups were formed based on age at surgery: Group 1, younger than 2 years, and Group 2, older than 2 years. All eyes in Group 1 (n = 37) had primary posterior continuous curvilinear capsulorhexis (PCCC) with anterior vitrectomy. In Group 2 (n = 66), management of the posterior capsule was assigned randomly to no PCCC (Group 2A, n = 37) or PCCC (Group 2B, n = 29). The PCCC group was further randomized into 2 subgroups: no vitrectomy (Group 2BN, n = 14) or vitrectomy (Group 2BV, n = 15). The primary outcome measures were visual axis opacification and the resulting need for a secondary procedure. Statistical analysis was performed using SPSS for Windows (version 11.0.1). Results: The mean age of the patients was 5.2 years ± 5.0 (SD) (range 0.2 to 16.0 years) and the mean follow-up, 2.3 ± 0.9 years (range 1.0 to 4.0 years). Overall, 41 eyes (39.8%) developed visual axis opacification and 14 (13.6%) required secondary intervention. In Group 1, 4 eyes (10.8%) developed visual axis opacification and 3 (8.1%) had a secondary pars plana vitrectomy. In Group 2A, 31 eyes (83.8%) developed posterior capsule opacification (PCO) and 10 eyes (27.7%) had secondary intervention. Children 8 years or younger at the time of surgery developed significantly greater PCO than older children (P = .01). Five eyes (37.5%) in Group 2BN had opacification of the anterior vitreous face, 1 of which required a secondary procedure. One eye (6.7%) in Group 2BV had visual axis opacification that did not require a secondary procedure. Conclusions: AcrySof IOL implantation with appropriate management of the posterior capsule maintained a clear visual axis in 60.2% of eyes. Of the 39.8% of eyes with visual axis opacification, 13.6% had visually significant opacification and required a secondary procedure. A prospective study of 103 pediatric eyes that were randomly assigned different techniques of posterior capsule management revealed satisfactory visual axis clarity and a low incidence of the need for a secondary procedure." @default.
• W2024868083 created "2016-06-24" @default.
• W2024868083 creator A5007227702 @default.
• W2024868083 creator A5050829488 @default.
• W2024868083 creator A5075286351 @default.
• W2024868083 date "2004-05-01" @default.
• W2024868083 modified "2023-10-13" @default.
• W2024868083 title "Visual axis opacification after AcrySof intraocular lens implantation in children" @default.
• W2024868083 cites W1535516805 @default.
• W2024868083 cites W1969029123 @default.
• W2024868083 cites W1970674736 @default.
• W2024868083 cites W1974902957 @default.
• W2024868083 cites W1978875014 @default.
• W2024868083 cites W1984295019 @default.
• W2024868083 cites W1984826006 @default.
• W2024868083 cites W1992649702 @default.
• W2024868083 cites W1995530402 @default.
• W2024868083 cites W2001373039 @default.
• W2024868083 cites W2005857608 @default.
• W2024868083 cites W2011239646 @default.
• W2024868083 cites W2019534225 @default.
• W2024868083 cites W2019983245 @default.
• W2024868083 cites W2022116196 @default.
• W2024868083 cites W2024418373 @default.
• W2024868083 cites W2028541168 @default.
• W2024868083 cites W2042001068 @default.
• W2024868083 cites W2044659754 @default.
• W2024868083 cites W2047638470 @default.
• W2024868083 cites W2050876756 @default.
• W2024868083 cites W2059906778 @default.
• W2024868083 cites W2064190343 @default.
• W2024868083 cites W2070188012 @default.
• W2024868083 cites W2073106023 @default.
• W2024868083 cites W2076069174 @default.
• W2024868083 cites W2078237794 @default.
• W2024868083 cites W2080079242 @default.
• W2024868083 cites W2081865543 @default.
• W2024868083 cites W2083618780 @default.
• W2024868083 cites W2085819229 @default.
• W2024868083 cites W2092153746 @default.
• W2024868083 cites W2094510171 @default.
• W2024868083 cites W2099111005 @default.
• W2024868083 cites W2156607579 @default.
• W2024868083 cites W2156970668 @default.
• W2024868083 cites W2166326916 @default.
• W2024868083 cites W2245561847 @default.
• W2024868083 cites W2266306729 @default.
• W2024868083 cites W2298195809 @default.
• W2024868083 doi "https://doi.org/10.1016/j.jcrs.2003.08.020" @default.
• W2024868083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15130646" @default.
• W2024868083 hasPublicationYear "2004" @default.
• W2024868083 type Work @default.
• W2024868083 sameAs 2024868083 @default.
• W2024868083 citedByCount "63" @default.
• W2024868083 countsByYear W20248680832012 @default.
• W2024868083 countsByYear W20248680832013 @default.
• W2024868083 countsByYear W20248680832014 @default.
• W2024868083 countsByYear W20248680832015 @default.
• W2024868083 countsByYear W20248680832016 @default.
• W2024868083 countsByYear W20248680832017 @default.
• W2024868083 countsByYear W20248680832018 @default.
• W2024868083 countsByYear W20248680832019 @default.
• W2024868083 countsByYear W20248680832020 @default.
• W2024868083 countsByYear W20248680832021 @default.
• W2024868083 countsByYear W20248680832022 @default.
• W2024868083 countsByYear W20248680832023 @default.
• W2024868083 crossrefType "journal-article" @default.
• W2024868083 hasAuthorship W2024868083A5007227702 @default.
• W2024868083 hasAuthorship W2024868083A5050829488 @default.
• W2024868083 hasAuthorship W2024868083A5075286351 @default.
• W2024868083 hasConcept C118487528 @default.
• W2024868083 hasConcept C141071460 @default.
• W2024868083 hasConcept C2777063560 @default.
• W2024868083 hasConcept C2778257484 @default.
• W2024868083 hasConcept C2779567214 @default.
• W2024868083 hasConcept C2779996494 @default.
• W2024868083 hasConcept C2781104129 @default.
• W2024868083 hasConcept C2781242345 @default.
• W2024868083 hasConcept C2910242117 @default.
• W2024868083 hasConcept C71924100 @default.
• W2024868083 hasConceptScore W2024868083C118487528 @default.
• W2024868083 hasConceptScore W2024868083C141071460 @default.
• W2024868083 hasConceptScore W2024868083C2777063560 @default.
• W2024868083 hasConceptScore W2024868083C2778257484 @default.
• W2024868083 hasConceptScore W2024868083C2779567214 @default.
• W2024868083 hasConceptScore W2024868083C2779996494 @default.
• W2024868083 hasConceptScore W2024868083C2781104129 @default.
• W2024868083 hasConceptScore W2024868083C2781242345 @default.
• W2024868083 hasConceptScore W2024868083C2910242117 @default.
• W2024868083 hasConceptScore W2024868083C71924100 @default.
• W2024868083 hasIssue "5" @default.
• W2024868083 hasLocation W20248680831 @default.
• W2024868083 hasLocation W20248680832 @default.
• W2024868083 hasOpenAccess W2024868083 @default.
• W2024868083 hasPrimaryLocation W20248680831 @default.
• W2024868083 hasRelatedWork W2018576074 @default.
• W2024868083 hasRelatedWork W2065536155 @default.
• W2024868083 hasRelatedWork W2358596552 @default.

• next